
This study aimed to determine the ability of retrospective cardiometabolic disease staging (CMDS) and social determinants of health (SDoH) to predict COVID‐19 outcomes. A total of 2,873 patients were identified (mean age: 58 years [SD 13.2], 59% were female, 45% were Black). Retrospective clinical markers of cardiometabolic disease and SDoH were independently predictive of COVID‐19 outcomes in the population.
Like
Save
Share